Amarantus Bioscience Holdings, Inc. (AMBS) - OTCQB
From other sites
Company Description
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing therapeutics and diagnostics for neurological disorders and orphan diseases. AMBS owns licensing rights to the small molecule drug candidate eltoprazine ("eltoprazine"), indicated for Parkinson's disease Levodopa induced... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States